Survival Study of the Genutech® Total Knee Arthroplasty
Launched by HOSPITAL DE SANT RAFAEL · Mar 27, 2025
Trial Information
Current as of April 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the Genutech® total knee arthroplasty, a type of surgery for people with knee osteoarthritis, which is a condition that causes pain and stiffness in the knee. The trial aims to understand how well this specific knee replacement procedure works for patients who have not found relief from other treatments. The study is currently looking for participants aged 18 and older who have knee osteoarthritis and are planning to receive a Genutech® knee prosthesis at the hospital where the study is taking place.
To be eligible for the study, participants should not have had a total knee replacement in the same knee before, and they must be able to give their consent to join the study. People who participate can expect regular follow-ups to assess their recovery and how well the new knee is functioning. It's important to know that this study is focused on gathering information to improve future treatments for knee osteoarthritis, so your participation could help others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 18 years with knee osteoarthritis that had not responded to conservative treatment
- • capable of providing informed consent
- • patients who receive a Genutech® total knee prosthesis at the investigators' Institution.
- Exclusion Criteria:
- • having received a prior total knee arthroplasty in the same joint
- • inability to provide informed consent
- • not willing to participate in the study
About Hospital De Sant Rafael
Hospital de Sant Rafael is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Renowned for its commitment to excellence in patient care, the hospital fosters a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By prioritizing ethical standards and patient safety, Hospital de Sant Rafael aims to contribute significantly to the medical community, driving forward advancements in treatment options across various therapeutic areas. Its robust infrastructure and experienced team ensure the successful execution of trials that adhere to the highest regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported